Dr Johanna Feary
Changing prevalence of current asthma and inhaled corticosteroid treatment in the UK: population-based cohort 2006–2016
Asthma is the most common respiratory disorder in the UK, yet we have incomplete knowledge on the prevalence of current disease, treatment and exacerbations.
We used UK electronic healthcare records, 2006–2016, to estimate the prevalence of current asthma by year, sex and age (<5, 5–11, 12–17, 18–24, 25–54 and ≥55 years), and the proportion prescribed inhaled corticosteroids (ICS) and additional asthma therapy, treated for exacerbations and other asthma care markers.
Biallelic human ITCH variants causing a multisystem disease with dysmorphic features: a second report
We report a 23 year old female with biallelic truncating variants in the ITCH (Itchy E3 Ubiquitin protein ligase, mouse homolog of; OMIM60649) gene associated with marked short stature, severe early onset chronic lung disease resembling asthma, dysmorphic facial features, and symmetrical camptodactyly of the fingers but normal intellect.
Aromatic solvents: the not so sweet side
In their published article, Alif et al report the findings from a carefully conducted longitudinal study showing the effects of occupational exposures on lung function decline between the ages of 45 and 50 years.
Laboratory animal allergy is preventable in modern research facilities
Basophil activation testing in occupational respiratory allergy to low molecular weight compounds
Purpose of review There is an unmet need for better immunological tests in cases of suspected occupational asthma to many workplace chemicals; here we consider the basophil activation test (BAT), a potential alternative to the detection of specific IgE antibodies.
Recent findings BAT is fairly widely used in general allergy services; and there is increasing experience of its use in the diagnosis of occupational allergy to low molecular weight agents and chemicals including wood dusts, persulphates, antibiotics and latex.
Continuous laryngoscopy during provocation in the assessment of inducible laryngeal obstruction
Transient paradoxical closure of the larynx, occurring in the absence of any underlying structural or neurological defect, is a recognized cause of paroxysmal breathlessness and wheeze. This phenomenon, most commonly termed vocal cord dysfunction and more recently termed inducible laryngeal obstruction (ILO),1 is often misdiagnosed and mistreated as asthma.2, 3 This may be explained by the lack of a robust, accepted diagnostic methodology.4, 5
Exacerbation patterns in adults with asthma in England. A population-based study
Rationale: Asthma is heterogeneous and knowledge on exacerbation patterns is lacking. Previous studies have had a relatively short follow-up or focused on severe disease.
Objectives: To describe exacerbation patterns over a prolonged follow-up in a population that includes patients of all disease severity.
Jo Feary speaks at All Party Parliamentary Party Group (APPG) on artificial/engineered stone
Mon, 03 Nov 2025
Dr Johanna Feary recently spoke to MPs and peers at the All Party Parliamentary Party Group (APPG) on Occupational Safety & Health on Monday 3 November 2025, about the increasing number of patients in the UK diagnosed with silicosis caused by artificial/engineered stone.
Industry experts at the Westminster meeting including clinicians, politicians, union leaders and legal teams called for a UK-wide ban on stones with high silica content, primarily artificial/engineered stone.
The meeting was hosted by Thompsons Solicitors and the Trade Union Congress.
Read press coverage of the meeting here:
Dr Johanna Feary speaking at Fire Committee assembly
Tue, 16 Sep 2025
Dr Johanna Feary took part in a live panel discussion as part of the Fire Committee with the London Assembly today. Dr Feary speaks about the Grenfell Firefighters Study from 01:11:10 (1hr 11mins). Watch the full discussion online at the Mayor of London website: https://webcasts.london.gov.uk/Assembly/Event/Index/23eb223f-e51f-4ebd-9043-9db7d6c77144
Read more about our work on firefighters' lung health.
EPICOH 2025 conference
Sun, 05 Oct 2025
Dr Johanna Feary recently presented at the EPICOH 2025 conference held between 5-9th October 2025 in Utrecht, the Netherlands on artificial stone silicosis.
They did talks alongside leaders in the field from Australia and the UK (L-R: Malcolm Sim, Martie Van Tongeren, Johanna Feary, Ryan Hoy, Deborah Glass, Karen Walker-Bone).
Read more about education and training we provide.
